United States — Fargo, North Dakota

United States is a clinical research site located in Fargo, North Dakota, United States 58103.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

United States has participated in 1 clinical trials.

Therapeutic areas: Mesopic Vision, Night Vision Loss.

Sponsors: Ocuphire Pharma, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fargo

Browse all research sites in North Dakota · View every site in Fargo

• Essentia Health Innovis Hospital
• Dakota Cancer Institute at Dakota Clinic - South University
• North Dakota State University/Sanford Health
• Veterans Affairs Medical Center - Fargo
• Meritcare Hospital
• Dakota Clinicl / Innovis Hospital
• Veterans Administration Medical Center
• Fargo VA Medical Center
• North Dakota State University Health, Nutrition, and Exercise Sciences
• CCOP - Merit Care Hospital
• Sanford Children's Hospital
• Sanford South University Medical Center

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States?

United States has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States conducted?

United States has 1 clinical trials on record. Their work covers Mesopic Vision, Night Vision Loss.

Is United States accredited by Crixeo Clinical Trials?

United States has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.